FindMyKOL
Clinical trialNCT00335517CompletedInterventional

Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients

NCT00335517 is an interventional trial sponsored by University of Rochester. As of 21 Nov 2026, it is completed. It studies DepoDur in Lumbar Spine Surgery. The registry lists an enrollment of 98 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2006 and a primary completion date of 30 Sept 2010.

SponsorUniversity of Rochester →Enrollment98Lumbar Spine Surgery
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00335517
FieldValue
Registry IDNCT00335517
StatusCompleted
Study typeInterventional trial
Lead sponsorUniversity of Rochester
Enrollment98
Registered sites1
Countries1
ConditionsLumbar Spine Surgery
DrugsDepoDur
Start30 Jun 2006
Primary completion30 Sept 2010
Study completion30 Nov 2010
Last update posted19 Dec 2014

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • University of Rochester Medical Center

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DepoDur
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT00335517

Each answer restates registry values shown on this page.

What is NCT00335517?

NCT00335517 is an interventional trial sponsored by University of Rochester. It studies DepoDur in Lumbar Spine Surgery.

Who leads NCT00335517?

The registry names Rechtine Glenn, MD (principal investigator, University of Rochester) as the overall official.

Where does NCT00335517 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT00335517 study?

The registered drug and biological interventions are DepoDur.

When did NCT00335517 end?

The registry lists a primary completion date of 30 Sept 2010 and a study completion date of 30 Nov 2010. The sponsor last updated the record on 19 Dec 2014.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.